This Plain Language Summary of Publication article (PLSP) from Expert Review of Ophthalmology presents 6-month results from the BALATON and COMINO clinical studies comparing faricimab, a new drug that blocks both vascular endothelial growth factor (VEGF) and angiopoetin-2 proteins, with aflibercept, an established treatment that blocks only VEGF, for treating macular edema due to retinal vein occlusion (RVO). RVO occurs when a vein in the retina becomes blocked, causing fluid buildup in the macula (central retina) and affecting vision.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion’ and was published in Ophthalmology.

Visit American Academy of Opthamology using the link to read the original article.